← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #514 OF 1,000 MOST-CITED

Suitability of testing methods verified

FDA cited this observation 37 times across 35 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs37
BY FISCAL YEAR
FY20262
FY20255
FY20243
FY20234
FY20221
FY20214
FY20204
FY20196
FY20185
FY20173

How FDA worded it — real examples

The suitability of all testing methods is not verified under actual conditions of use.

Atlantic Analytical Laboratories LLC · Whitehouse, New Jersey · Drugs · 2026-03-17

The suitability of all testing methods is not verified under actual conditions of use.

EO Products, LLC · San Rafael, California · Drugs · 2025-10-23

The suitability of all testing methods is not verified under actual conditions of use.

Unilever Manufacturing (US), Inc. · Jonesboro, Arkansas · Drugs · 2025-09-15

The suitability of all testing methods is not verified under actual conditions of use.

Beckman Research Institute, City of Hope · Duarte, California · Drugs · 2025-08-20

The suitability of all testing methods is not verified under actual conditions of use.

Creative Essences Inc · Santa Fe Springs, California · Drugs · 2025-03-25

The suitability of all testing methods is not verified under actual conditions of use.

Acupac Packaging Inc · Mahwah, New Jersey · Drugs · 2025-03-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →